Abstract
Long-term prostaglandin use is commonly associated with side effects such as cortical proliferation of the bones, hypertrophic pyloric stenosis, and soft tissue swelling of the extremities. We report a neonate with critical coarctation of the aorta, who developed second and third degree atrioventricular blocks associated with prolonged prostaglandin E1 (PGE1) infusion. Interestingly, these conduction blocks only occurred at low PGE1 dose. The rhythm disturbances resolved promptly with the discontinuation of PGE1 following surgical repair.
References
Beamish RE, Das PK, Karmazyn M, Dhalla NS (1985) Prostaglandins and heart disease. Can J Cardiol 1:66–74
Bourke KD, Sondheimer HM, Ivy DD, Pietra B, Gleason BK, Mashburn C, Boucek MM (2003) Improved pretransplant management of infants with hypoplastic left heart syndrome enables discharge to home while waiting for transplantation. Pediatr Cardiol 24:538–543
Aykanat A, Yavuz T, Ozalkaya E, Topcuoglu S, Ovali F, Karatekin G (2016) Long-term prostaglandin E1 infusion for newborns with critical congenital heart disease. Pediatr Cardiol 37:131–134
Peled N, Dagan O, Babyn P, Silver MM, Barker G, Hellmann J, Scolnik D, Koren G (1992) Gastric-outlet obstruction induced by prostaglandin therapy in neonates. N Engl J Med 327:505–510
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dea460fa-d05e-4191-8461-f185a711ad89. Accessed 31 March 2017
Alhussin W, Verklan MT (2016) Complications of long-term prostaglandin E1 use in newborns with ductal-dependent critical congenital heart disease. J Perinat Neonatal Nurs 30:73–79
Ustun N, Dilli D, Zenciroglu A, Okumus N, Cinar G, Ozgur S, Koc M (2013) Long-term prostaglandin E1 use in newborns with duct-dependent congenital heart diseases: one year experience of a tertiary neonatal intensive care unit in Turkey. Anadolu Kardiyol Derg 13:732–734
Lewis AB, Freed MD, Heymann MA, Roehl SL, Kensey RC (1981) Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64:893–898
De Smit E, Theodorou M, Hildebrand GD, Bloom P (2011) Heart block following topical latanoprost treatment. BMJ Case Rep. doi:10.1136/bcr.08.2011.4607
Swift A, Karmazyn M, Horrobin DF, Manku MS, Karmali RA, Morgan RO, Ally AI (1978) Low prostaglandin concentrations cause cardiac rhythm disturbances. Effect reversed by low levels of copper or chloroquine. Prostaglandins 15:651–657
Karmazyn M, Dhalla NS (1980) A selective concentration-dependent dysrhythmogenic and antidysrhythmic action of prostaglandins E2, F2 alpha and I2 (prostacyclin) on isolated rat hearts. Experientia 36:996–998
Rao TS, Seth SD, Manchanda SC, Nayar U (1989) Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis. Arch Int Pharmacodyn Ther 302:128–144
Anderson RH, Becker AE, Arnold R, Wilkinson JL (1974) The conducting tissues in congenitally corrected transposition. Circulation 50:911–923
Baruteau AE, Pass RH, Thambo JB, Behaghel A, Le Pennec S, Perdreau E, Combes N, Liberman L, McLeod CJ (2016) Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management. Eur J Pediatr 175:1235–1248
Johansen AS, Herlin T (1998) Neonatal lupus syndrome. Association with complete congenital atrioventricular block. Ugeskr Laeger 160:2521–2525
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Aly, S.A., Awad, S.M., Abdulla, Ri. et al. Chronic Low Dose Prostaglandin and Neonatal Heart Block. Pediatr Cardiol 38, 1515–1518 (2017). https://doi.org/10.1007/s00246-017-1633-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-017-1633-6